Acotec Scientific Holdings Ltd
HKEX:6669
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acotec Scientific Holdings Ltd
HKEX:6669
|
CN |
|
G
|
Guangzhou Lushan New Materials Co Ltd
SSE:603051
|
CN |
Income Statement
Earnings Waterfall
Acotec Scientific Holdings Ltd
Income Statement
Acotec Scientific Holdings Ltd
| Mar-2021 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
4
|
1
|
1
|
5
|
10
|
11
|
10
|
0
|
0
|
|
| Revenue |
296
N/A
|
334
+13%
|
304
-9%
|
479
+58%
|
396
-17%
|
463
+17%
|
474
+2%
|
523
+10%
|
534
+2%
|
593
+11%
|
645
+9%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(44)
|
(47)
|
(38)
|
(68)
|
(59)
|
(77)
|
(96)
|
(124)
|
(131)
|
(147)
|
(168)
|
|
| Gross Profit |
251
N/A
|
287
+14%
|
266
-7%
|
411
+54%
|
336
-18%
|
387
+15%
|
377
-2%
|
400
+6%
|
403
+1%
|
446
+11%
|
476
+7%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(275)
|
(297)
|
(284)
|
(419)
|
(337)
|
(371)
|
(354)
|
(369)
|
(365)
|
(366)
|
(358)
|
|
| Selling, General & Administrative |
(147)
|
(154)
|
(116)
|
(175)
|
(161)
|
(186)
|
(181)
|
(181)
|
(158)
|
(167)
|
(182)
|
|
| Research & Development |
(124)
|
(141)
|
(141)
|
(218)
|
(184)
|
(197)
|
(190)
|
(201)
|
(217)
|
(219)
|
(214)
|
|
| Depreciation & Amortization |
(9)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
5
|
8
|
(27)
|
(26)
|
7
|
12
|
17
|
13
|
9
|
20
|
38
|
|
| Operating Income |
(23)
N/A
|
(9)
+61%
|
(18)
-99%
|
(8)
+55%
|
(1)
+88%
|
16
N/A
|
23
+46%
|
31
+33%
|
38
+23%
|
80
+112%
|
118
+48%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(2)
|
(1)
|
(8)
|
14
|
72
|
46
|
(8)
|
9
|
23
|
23
|
6
|
|
| Non-Reccuring Items |
(22)
|
(28)
|
(41)
|
(41)
|
(0)
|
0
|
(0)
|
(7)
|
(7)
|
(0)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(48)
N/A
|
(38)
+20%
|
(67)
-77%
|
(36)
+47%
|
70
N/A
|
61
-13%
|
14
-76%
|
32
+122%
|
53
+64%
|
102
+94%
|
122
+20%
|
|
| Net Income | ||||||||||||
| Tax Provision |
(16)
|
(19)
|
(12)
|
(12)
|
(0)
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
|
| Income from Continuing Operations |
(64)
|
(57)
|
(79)
|
(48)
|
70
|
61
|
14
|
32
|
52
|
101
|
119
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(63)
N/A
|
(56)
+11%
|
(79)
-40%
|
(48)
+39%
|
70
N/A
|
61
-12%
|
14
-76%
|
32
+121%
|
52
+63%
|
101
+93%
|
119
+18%
|
|
| EPS (Diluted) |
-0.2
N/A
|
-0.18
+10%
|
-0.32
-78%
|
-0.15
+53%
|
0.23
N/A
|
0.2
-13%
|
0.05
-75%
|
0.11
+120%
|
0.17
+55%
|
0.33
+94%
|
0.39
+18%
|
|